CLINICAL USEFULNESS OF D-DIMER - EVALUATION DURING FIBRINOLYTIC TREATMENT OF VENOUS THROMBOSIS OR MYOCARDIAL-INFARCTION

被引：5

作者：

SIMANK, HG

SIMON, M

BODE, C

ZIMMERMANN, R

KUBLER, W

WEBER, E

机构：

来源：

关键词：

D O I：

10.1016/0049-3848(89)90238-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：541 / 546

页数：6

共 7 条

[1] AMIRAL J, 1986, FIBRINOGEN ITS DERIV, P285
[2] DECLERCK PJ, 1987, THROMB HAEMOSTASIS, V58, P1024
[3] EVOLUTION OF PLASMA SPECIFIC FIBRIN DEGRADATION PRODUCTS DURING THROMBOLYTIC THERAPY IN PATIENTS WITH THROMBOEMBOLISM
FAIVRE, R
MIRSHAHI, M
DUCELLIER, D
SORIA, J
MIRSHAHI, M
KIEFFER, Y
BASSAND, JP
CAEN, J
MAURAT, JP
[J]. THROMBOSIS RESEARCH, 1988, 50 (04) : 583 - 589
[4] LYSIS OF CROSSLINKED HUMAN FIBRIN BY PLASMIN YIELDS INITIALLY A SINGLE MOLECULAR-COMPLEX, D DIMER-E
GAFFNEY, PJ
JOE, F
[J]. THROMBOSIS RESEARCH, 1979, 15 (5-6) : 673 - 687
[5] PLASMIN DEGRADATION OF CROSS-LINKED FIBRIN
MARDER, VJ
FRANCIS, CW
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1983, 408 (JUN) : 397 - 406
[6] ROWBOTHAM BJ, 1987, THROMB HAEMOSTASIS, V57, P59
[7] VERSTRAETE M, 1985, J PHARMACOL EXP THER, V235, P506